Skip to Content
주식/증권 📈 긍정적

BofA upgrades Moderna after 177% rally driven by cancer vaccine breakthrough

Yahoo Finance 08/20/2026 07:32:38 AM 4회
요약

Investing.com -- Bank of America upgraded Moderna to Neutral with a $170 price objective, following a sharp rally in the stock after positive data on its personalized cancer vaccine, intismeran, in adjuvant melanoma.

원문 기사 보기
관련 뉴스
Panoro Energy ASA GAAP EPS of -$0.06, revenue of $25.4M
08/20/2026
VGP SA reports 1H results
08/20/2026
CTO Realty Growth, Inc. 6.375% SER A PFD declares $0.3984 dividend
08/20/2026
Moderna nearly triples in record S&P 500 move, but analyst sees more volatility ahead
08/20/2026
뉴스 목록으로